Ann: 4DMedical webinar with Dr David Shulkin, page-34

Thanks @Connex. Happy to have you and @StuTM here - both I understand invested reasonably early in PME and have done well from it; hoping this is good omen for us in 4DX.

I was glad to hear today Dr Shulkin speak highly of XV tech and is able to succinctly explain its value proposition including that it is non-invasive, can accurately diagnose CB, cost effective compared to the lung biopsy. If he's doing the same with his VA connections, then hopefully it cuts through.

I also liked his mention of using this potentially for the wider cohort of Veterans impacted, like StuTM mentioned. He talked about potential overlaying our technology with an initial CT scan as a option for veterans needing further health assessment following initial screening, and that it can help diagnose not just CB but other lung anomalies the veteran could be suffering from - where he pointed out the lung biopsy is useful for just CB diagnosis.

Like others, I assume he has other main business being here in Australia with the 4DMedical team.

Let's not forget the VA potential is just one aspect of our Australia / US commercialisation pipeline.